Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Neil MacIntyre

Critical Care Medicine Durham, NC Medical Doctor

NPI 1336202118 CMS profile 332579

2100 Erwin Rd, Rm 1120, Durham, NC 27710

Open in the dashboard

General payments

$70,350

55 records reported · program years 2019–2025

Research payments

$22,598

Paid to them · 7 records reported · program years 2019–2025

Ownership & investment interest

$9,600

1 holding reported · through program year 2025

Research they led as principal investigator

$9,022 paid to institutions, not to them · program year 2021

Through program year 2025, Neil MacIntyre of Durham, NC is reported in the CMS Open Payments database as having received $70,350 across 55 general payments and $22,598 in research payments paid to them. Separately, studies naming them as principal investigator received $9,022 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $9,600 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,668 2
2025 Research $2,408 1
2024 Research $7,140 3
2023 General $5,275 3
2022 General $12,934 12
2021 General $355 1
2020 General $10,592 15
2019 General $37,526 22
2019 Research $13,050 3
2020 Ownership $9,600 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Neil MacIntyre
  • Critical Care Medicine median
  • Middle half of Critical Care Medicine
  • National median

In program year 2025, general payments to Neil MacIntyre were reported at $3,668. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.

Show as a table
Year Neil MacIntyre Critical Care Medicine median Middle half National median
2019 $37,526 $149 $51–$535 $163
2020 $10,592 $110 $30–$325 $114
2021 $355 $125 $34–$403 $132
2022 $12,934 $157 $49–$582 $149
2023 $5,275 $162 $56–$621 $160
2024 $0 $168 $53–$634 $164
2025 $3,668 $189 $59–$844 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Breathe Technologies, Inc. $28,759 12 payments
  2. Inogen, Inc. $9,500 6 payments
  3. Mylan Specialty L.P. $5,573 7 payments
  4. GlaxoSmithKline, LLC. $5,357 6 payments
  5. Advanced Respiratory, Inc $5,005 7 payments
  6. Medtronic, Inc. $4,511 6 payments
  7. Vyaire Medical, Inc. $4,083 3 payments
  8. Genentech, Inc. $3,668 2 payments
  9. Pulmonx Corporation $2,450 2 payments
  10. Covidien LP $810 1 payment
  11. Other $634 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $47,506 23 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,233 6 payments
  3. Current or prospective ownership or investment interest $6,116 2 payments
  4. Travel and Lodging $2,311 9 payments
  5. Honoraria $1,500 1 payment
  6. Food and Beverage $684 14 payments
Products named General payments · program years 2019–2025
  1. Life2000 Ventilation System $28,759 12 payments
  2. InogenOne $6,000 4 payments
  3. Yupelri $5,573 7 payments
  4. Life 2000 Ventilation System $4,935 6 payments
  5. Nellcor Pulse Oximetry $4,511 6 payments
  6. INOGEN $3,500 2 payments
  7. Pulmonx Endobronchial Valve EBV $2,450 2 payments
  8. Nellcor Pulse Oximetry $810 1 payment
  9. (9520) IGT Devices Undivided $470 1 payment
  10. Aerobika $150 1 payment
  11. Other $186 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Teleflex Medical Incorporated $13,050 3 payments
  2. Genentech, Inc. $9,548 4 payments

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$48,109

Medicare's payments for the services billed

Medicare patients

1,241

Average age 71

Services billed

2,472

684 women, 557 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 48%
COPD 44%
Chronic kidney disease 38%
Ischemic heart disease 37%
Diabetes 32%
Heart failure 29%
Atrial fibrillation 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

62 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Critical Care Medicine in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record